Pfizer Stock Dives; Why Lilly’s Zepbound Still Looks Like The Weight-Loss Heavyweight

An analyst says Eli Lilly's Zepbound still looks like the heavyweight in weight loss compared to Pfizer's injection. Pfizer stock fell.

Published: February 3, 2026 5:05 pm

Source: Investor's Business Daily — Read original